Chopas James George, VP and Chief Accounting Officer at Apellis Pharmaceuticals ($APLS), made six open market sales of company stock over the last year, totaling $103 thousand. His most recent sale occurred on January 22, 2026. These transactions rank 9,528th among 11,678 insiders in our database, well below the average sale value of $8.6 million and average of 6.4 transactions per insider. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 16150 | $0.00 | 65,955.0000 | 130,067,000 | 32.43% | 0.01% |
| Jan. 22, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 2064 | $21.77 | 49,805.0000 | 130,067,000 | 3.98% | 0.00% |
| Jan. 20, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 726 | $19.79 | 51,869.0000 | 130,067,000 | 1.38% | 0.00% |
| Jan. 13, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 873 | $22.19 | 52,595.0000 | 130,067,000 | 1.63% | 0.00% |
| Sept. 15, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 189 | $24.19 | 53,468.0000 | 123,905,000 | 0.35% | 0.00% |
| Sept. 2, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 548 | $28.08 | 53,657.0000 | 123,905,000 | 1.01% | 0.00% |
| June 18, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 6250 | $0.00 | 54,205.0000 | 123,905,000 | 13.03% | 0.01% |
| June 9, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Stock Option (Right to Buy) | 11250 | $19.39 | 11,250.0000 | 123,905,000 | 9999.99% | 0.01% |
| March 17, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 183 | $24.82 | 47,955.0000 | 123,905,000 | 0.38% | 0.00% |
| Jan. 22, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 1096 | $30.43 | 48,138.0000 | 123,905,000 | 2.23% | 0.00% |
| Jan. 17, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 715 | $29.96 | 36,643.0000 | 123,905,000 | 1.91% | 0.00% |
| Jan. 21, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 12591 | $0.00 | 49,234.0000 | 123,905,000 | 34.36% | 0.01% |
| Jan. 13, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 783 | $28.70 | 37,358.0000 | 123,905,000 | 2.05% | 0.00% |
| Sept. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 192 | $36.21 | 38,141.0000 | 118,678,000 | 0.50% | 0.00% |
| Sept. 3, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 550 | $39.49 | 38,333.0000 | 118,678,000 | 1.41% | 0.00% |
| March 15, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 184 | $56.46 | 38,883.0000 | 118,678,000 | 0.47% | 0.00% |
| Jan. 22, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 1061 | $65.00 | 39,067.0000 | 118,678,000 | 2.64% | 0.00% |
| Jan. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Stock Option (Right to Buy) | 12086 | $66.30 | 12,086.0000 | 118,678,000 | 9999.99% | 0.01% |
| Jan. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 864 | $66.81 | 40,128.0000 | 118,678,000 | 2.11% | 0.00% |
| Jan. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 8312 | $0.00 | 40,992.0000 | 118,678,000 | 25.43% | 0.01% |
| Oct. 23, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 132 | $46.04 | 32,680.0000 | 106,114,000 | 0.40% | 0.00% |
| Sept. 14, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 2500 | $0.00 | 32,812.0000 | 106,114,000 | 8.25% | 0.00% |
| Aug. 31, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 551 | $41.23 | 30,312.0000 | 106,114,000 | 1.79% | 0.00% |
| Feb. 21, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | F | Common Stock | 334 | $58.50 | 30,863.0000 | 106,114,000 | 1.07% | 0.00% |
| Feb. 21, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Stock Option (Right to Buy) | 5737 | $0.00 | 5,737.0000 | 106,114,000 | 9999.99% | 0.01% |
| Feb. 21, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 4044 | $0.00 | 31,197.0000 | 106,114,000 | 14.89% | 0.00% |
| Jan. 20, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | F | Common Stock | 919 | $52.05 | 27,153.0000 | 106,114,000 | 3.27% | 0.00% |
| Jan. 12, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Stock Option (Right to Buy) | 15114 | $52.66 | 15,114.0000 | 106,114,000 | 9999.99% | 0.01% |
| Jan. 12, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 9621 | $0.00 | 28,072.0000 | 106,114,000 | 52.14% | 0.01% |